AARTIDRUGS / FY26 summary

The year in one view.

Aarti Drugs · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

1,976

₹ Cr where applicable

PAT across quarters

141.5

₹ Cr where applicable

Source quarters

3

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 84.4 · Positive source sentiment · 2025-11-06Q2 FY26Q3 FY26: 56.3 · Watch source sentiment · 2026-02-10Q3 FY26Q4 FY26: 96.6 · Watch source sentiment · 2026-04-30Q4 FY2696.656.3
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.